Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Cidara Therapeutics Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.cidara.com
Year Founded: 2012
Status: Public
Industry Sector: HealthTechnology
CEO: Jeffrey L. Stein, PhD
Number Of Employees: 38
Enterprise Value: $-21,922,919
PE Ratio: -0.75
Exchange/Ticker 1: NASDAQ:CDTX
Exchange/Ticker 2: N/A
Latest Market Cap: $236,376,496
BioCentury | Mar 25, 2025
Management Tracks
Warp Speed veteran Hepburn named EVP of R&D at Panther
Plus: Elicio names Preetam Shah CFO and chief strategy officer, and updates from Halozyme, Newron and Skye
BioCentury | Feb 20, 2025
Management Tracks
Bourla becomes chair of PhRMA
Plus: Steve Worland named CEO of Atomwise and updates from Ona, Cidara and Biosion
BioCentury | Jan 11, 2025
Management Tracks
Faces in new places ahead of JPM: Rubin joining Guggenheim
Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more
BioCentury | Jan 9, 2025
Management Tracks
Bayer vet Moeller to lead Antag
Plus: CMO changes at Sunbird and Cidara, and updates from Aicuris, Renovaro, Noema and more
BioCentury | Nov 23, 2024
Finance
ATB’s €54M series A among largest ever in Belgium
BioCentury’s Financial Report also includes new biotech foundry Jupiter, and public equity fundings for Spyre, Cidara and Aclaris
BioCentury | Nov 20, 2024
Product Development
Biotechs now match pharma for FDA approvals
Half of FDA approvals are sponsored by biotechs; almost all are marketing in the U.S. themselves
BioCentury | Oct 19, 2024
Finance
Biotech restructurings show signs of slowing
Temporary respite or reflection of a stabilizing sector?
BioCentury | Aug 20, 2024
Management Tracks
Toraishi steps down from Rakuten Medical as co-CEO
Plus: SalioGen hired Kalliopi Stasi as CMO and updates from PepGen, Cidara and Bio-Rad
BioCentury | Apr 30, 2024
Deals
Deals Report: BMS-Repertoire to develop vaccines for autoimmunity
Plus: Regeneron, Mammoth to make CRISPR-based gene editing therapies, and updates from Vertex-TreeFrog, Ono-Deciphera and more
BioCentury | Apr 27, 2024
Finance
Public equity report: Cidara resets with $240M PIPE
Plus: Centessa raises $100M in first follow-on since 2021 IPO
Items per page:
1 - 10 of 58